Clinical Trial Update: Impact of Sodium Glucose Co-transporter 2-Inhibitors on Clinical Outcome and Left Ventricular Function in Patients Presented by Acute Myocardial Infarction

View source ↗

Summary

A completed clinical trial evaluated the impact of SGLT2 inhibitors on clinical outcomes and left ventricular function in patients presenting with acute myocard…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Canagliflozin (canagliflozin)
• Dapagliflozin (dapagliflozin)
• Empagliflozin (empagliflozin)
• Ertugliflozin (ertugliflozin)

Snippet

Sponsor: Tanta University | Conditions: Sodium-glucose Cotransporter 2, Inhibitors | Status: COMPLETED